Founded in 2019 and incubated at IIT Bombay’s SINE, Ayati Devices builds a portfolio of portable, point-of-care diagnostic devices covering multiple stages of diabetic foot assessment. Its flagship products include Vibrasense (vibration perception threshold testing), Vibrasense+T (adds warm and cold perception testing), Vasosense (peripheral artery disease screening), Angiocam (real-time tissue perfusion imaging) and the PODIA Trolley pay-per-test screening model. The company reports deployments of more than 10,000 devices across 30 countries and says its solutions have enabled over 1 million screenings, with clinical deployments at leading healthcare institutions. Vibrasense has undergone clinical evaluation in a study of 562 people with type 2 diabetes comparing it to conventional biothesiometry and nerve conduction studies. Ayati plans to use new funding to accelerate commercialisation, expand domestic and international presence, strengthen manufacturing, and invest further in research and artificial intelligence.

Total raised

$2M

Funding rounds

1

Latest round

Series A

Latest activity

Aug 2026